期刊文献+

乙丙昔罗合成工艺的改进 被引量:1

Improved Synthesis of Efaproxiral
下载PDF
导出
摘要 目的改进变构血红蛋白调节剂乙丙昔罗的合成工艺.方法对羟基苯乙酸与3,5-二甲基苯胺在二甲苯中直接回流生成酰胺,后者与氢氧化钾、氯仿在丙酮中回流得乙丙昔罗.结果中间体N-(3,5-二甲苯基)-2-(4-羟基苯基)乙酰胺的收率为86%,产品的收率为85%,合成乙丙昔罗的总收率为73.1%.结论较大程度的降低了生产成本,优化了反应条件,适合于工业化生产. Objective To improve the synthetic procedure of RSR-13, an allosteric modifiers of hemoglobin. Methods The target compound was synthesized from 2- (4-hydroxyphenyl) acetic acid via refluxing in xylene with 3, 5-dimethylbenzenamine, and the produced N- (3, 5-dimethylphenyl) -2- (4- hydroxyphenyl) acetamider efluxing in acetone with Chloroform and Potassium hydroxide. Results The yield of N- (3, 5-dimethylphenyl) -2- (4-hydroxyphenyl) acetamide was 86%. The yield of efaproxiral was 85%. The overall yield was 73. 1%. Conelusion The advantage of low cost is suitable for industrial production.
出处 《河北北方学院学报(自然科学版)》 2008年第5期19-21,共3页 Journal of Hebei North University:Natural Science Edition
关键词 乙丙昔罗 变构血红蛋白调节剂 工艺改进 合成 efaproxiral allosteric modifier of hemoglobin improved synthesis synthesis
  • 相关文献

参考文献6

  • 1[1]Randad R S,Mahran M A,Abraham D J,et al.Allosteric modifiers of hemoglobin,design,synthesis,testing and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents[J].J Med Chem,1991,34:752-757 被引量:1
  • 2[2]Choy H,Nabid A,Stea B,et al.Improved local control with RSR13 and concurrent radiation therapy in a phase II study for locally advanced inoperable non-small cell lung cancer[J].Int J Radiat Oncol Biol Phys,2001,51(3,Suppl.1):2 254 被引量:1
  • 3[3]Shaw E,Scott C,Suh J,et al.RSR13 plus cranial radiation therapy in patients with brain metastases:Comparison with the radiation therapy oncology group recursive partitioning analysis brain metastases database[J].J Clin Oncol,2003,21:2 364-2 371 被引量:1
  • 4[4]Kleinberg L,Grossman S A,Plantadosi S,et al.PhaseI trial to determine the safety,pharmacodynamics,and pharmacokinetics of RSR13,a novel radioenhancer,in newly diagnosed glioblastoma multiforme[J].J Clin Oncol,1999,17:2 593-2 603 被引量:1
  • 5[5]Woods J A,Storey C J,Babcock E E,et al.Right shift the oxyhemoglobin dissociation curve with RSR13:effects on high-energy phosphates and myocardial recovery after low flow ischemia[J].J Cardiovasc Pharmacol 1998,31(2):359-363 被引量:1
  • 6杨辉,刘明峰,张嫡群,杨双革,赵兴茹.乙丙昔罗的合成[J].中国医药工业杂志,2007,38(7):470-471. 被引量:4

二级参考文献7

  • 1Kleinberg L,Grossman SA,Carson K,et al.Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy:results of a phase Ⅱ new approaches to brain tumor therapy CNS consortium safety and efficacy study[J].J Clin Oncol,2002,20(14):3149-3155. 被引量:1
  • 2Shaw E,Scott C,Suh J,et al.RSR13 Plus cranial radiation therapy in patients with brain metastases:comparison with the radiation therapy oncology group recursive partitioning analyses brain metastases database[J].J Clin Oncol,2003,21(12):2364-2371. 被引量:1
  • 3Grocott HP,Bart RD,Sheng HX,et al.Effects of a asynthetic allosteric modifier of hemoglobin oxygen affinity on outcome from global cerebral ischemia in the rat[J].Stroke,1998,29(8):1650-1655. 被引量:1
  • 4Abraham DJ,Wireko FC,Randad RS,et al.Allosteric modifiers of hemoglobin:2-[4-[[(3,5-disubstituted aniline) carbony] methyl] phenoxyl] -2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions,in whole blood,and in vivo in rats[J].Biochemistry,1992,31 (38):9141-9149. 被引量:1
  • 5Abraham DJ,Mehanna A,Randad R,et al.Preparation of allosteric hemoglobin modifiers:US,5049695[P].1991-09-17.(CA 1991,115:255817) 被引量:1
  • 6Randad RS,Mahran MA,Mehanna AS,et al.Allosteric modifiers of hemoglobin.1.Design,synthesis,testing,and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents[J].J Med Chem,1991,34 (2):752-757. 被引量:1
  • 7Grella MP,Danso-Danquah R,Safo MK,et al.Synthesis and structure-activity relationships of chiral allosteric modifiers of hemoglobin[J].J Med Chem,2000,43 (25):4726-4737. 被引量:1

共引文献3

同被引文献6

  • 1杨辉,刘明峰,张嫡群,杨双革,赵兴茹.乙丙昔罗的合成[J].中国医药工业杂志,2007,38(7):470-471. 被引量:4
  • 2Abraham D J, Perutz M F, Phillips S E V. Physiological and x-ray studies of potential antisickling agents [J]. Proc Natl Acad Sci USA, 1983, 80 (01): 324-328. 被引量:1
  • 3Wahr J A, Gerber M, Venitz J, et al. Allosteric Modification of Oxygen Delivery by Hemoglobin [J]. J Anesth Analg, 2001, 92 (03):615-620. 被引量:1
  • 4Kavanagh B D, Schmidt-Ullrich R K, Gerber M J. Clinical experience with radiotherapy and RSR13, a radiation-enhancing hemoglobin modifier, for epithelial carcinomas [J]. Proc Am Assoc Cancer Res, 1998, 39: 2219. 被引量:1
  • 5Wei E P. Randad R S,Levasseur J E, et al. Effect of Local Change in O2 Saturation of Hemoglobin on Cerebral Vasodilation from Hypoxia and Hypotension [J]. Am J Physiol, 1993, 265:1439-1443. 被引量:1
  • 6Breidbach A, Catlin D H. RSR13, a potential athletic performance enhancement agent: detection in urine by gas chromatography/mass spectrometry [J]. Rapid Commun Mass Spectrom, 2001, 15 (24):2379-2382. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部